9/21/2025

Novanta Inc. recently announced that Barbara Hulit resigned from its Board of Directors, Audit Committee, and ESG Committee, effective November 1, 2025, citing no disagreements with the company's practices or policies. At the same time, Novanta expanded its share repurchase authorization by US$200 million to a total of US$250 million, underscoring management’s confidence in the company’s value and capital allocation priorities. We'll examine how Novanta's expanded US$250 million buyback...

Source: Yahoo

9/19/2025

Novanta (NOVT) announced that its board of directors has authorized the repurchase of up to an additional $200M of the company’s outstanding common shares, adding capacity to the $31M remaining from its 2020 board authorization, for a total capacity of $231M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on NOVT: Novanta price target lowered to $133 from $139 at Baird Novanta Inc.

Source: Yahoo

9/19/2025

A number of stocks jumped in the afternoon session after investors scooped up equities, shaking off the initial concerns inferred from the Fed's dot plot, with tech stocks leading the charge.

Source: Yahoo

9/18/2025

BOSTON, September 18, 2025--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the repurchase of up to an additional $200 million of the Company’s outstanding common shares, adding capacity to the $31 million remaining from its 2020 Board authorization, for a total capacity of $231 million.

Source: Yahoo

9/16/2025

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Novanta (NASDAQ:NOVT) and its peers.

Source: Yahoo

9/10/2025

The following slide deck was published by Novanta Inc.

Source: SeekingAlpha

9/9/2025

MALVERN, Pa., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Vanguard Group, Inc. (“VGI”) has filed an early warning report on SEDAR+ (www.sedarplus.com) with respect to the common shares (“Shares”) of Novanta Inc. (the “Issuer”) controlled by VGI. The early warning report has been filed, and this press release is being issued, to disclose historical acquisition of Shares by VGI. Following the filing of the early warning report and the issuance of this press release, VGI intends to rely on the alternati

Source: Yahoo

9/4/2025

Brown Advisory, an investment management company, released its “Brown Advisory Small-Cap Growth Strategy” second-quarter 2025 investor letter. During the first half of the year, the Brown Advisory Small-Cap Growth Strategy delivered results consistent with its historical performance. A copy of the letter can be downloaded here. In the first quarter of 2025, the portfolio remained […]

Source: Yahoo

8/28/2025

Whether you see them or not, industrials businesses play a crucial part in our daily activities. They are also bound to benefit from a friendlier regulatory environment with the Trump administration, and this excitement has led to a six-month gain of 17.7% for the sector - higher than the S&P 500’s 8.8% return.

Source: Yahoo

8/14/2025

A number of stocks fell in the afternoon session after an unexpectedly sharp rise in wholesale inflation fueled concerns about rising costs and their impact on corporate profits. The primary catalyst was the July 2025 Producer Price Index (PPI), a measure of inflation at the wholesale level, which jumped 0.9% against forecasts of a 0.2% rise. This represents the most significant monthly increase in over three years, pointing to mounting cost pressures for manufacturers, with tariffs cited as a k

Source: Yahoo

8/13/2025

Novanta’s second quarter was marked by strong execution in its core medical and automation markets, but the market responded negatively to the results. Management pointed to robust double-digit growth in the Advanced Surgery and Robotics Automation businesses, driven by new product launches and sustained procedure growth in healthcare. CEO Matthijs Glastra highlighted the company’s new product revenue growing over 50% year-over-year and customer orders up 10%, indicating demand strength. However

Source: Yahoo

8/13/2025

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next quarter’s revenue guidance of $245.5 million was less impressive, coming in 3.8% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.6% above analysts’ consensus estimates.

Source: Yahoo

8/12/2025

BOSTON, August 12, 2025--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025, in New York, NY.

Source: Yahoo

8/6/2025

Novanta Inc (NOVT) reports robust new product revenue growth and strategic wins, despite facing headwinds in industrial and precision medicine sectors.

Source: Yahoo

8/6/2025

Novanta ( NASDAQ:NOVT ) Second Quarter 2025 Results Key Financial Results Revenue: US$241.0m (up 2.2% from 2Q 2024...

Source: Yahoo

8/5/2025

Novanta Inc. (NASDAQ:NOVT) Q2 2025 Earnings Conference Call August 5, 2025 10:00 AM ETCompany ParticipantsMatthijs Glastra - CEO & Chairman of the...

Source: SeekingAlpha

8/5/2025

Novanta (NOVT) delivered earnings and revenue surprises of +2.70% and +1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

8/5/2025

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next quarter’s revenue guidance of $245.5 million was less impressive, coming in 3.6% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.6% above analysts’ consensus estimates.

Source: Yahoo

8/5/2025

BEDFORD, Mass. AP) — Novanta Inc. NOVT) on Tuesday reported net income of $4.5 million in its second quarter.

Source: Yahoo

8/5/2025

BOSTON, August 05, 2025--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025.

Source: Yahoo